OPTI expands clinic network and plans U.S. entry pending approval
The company says it is growing its clinic network and preparing for U.S. entry, while it is commercial with psilocybin and MDMA products in Australia and Canada.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.